Sunesis Pharmaceuticals (NASDAQ: SNSS) disclosed in an SEC filing:
On April 7, 2017, Eric H. Bjerkholt, Executive Vice President, Corporate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE